Unipharm navigates tricky IPO market to raise €136m

Unipharm, the Irish healthcare services company, has managed to successfully price its €136m IPO in London and Dublin, despite price sensitivity among investors leading to the cancellation of two significant IPOs last week.

  • By Aidan Gregory
  • 15 Jul 2019

Despite equity markets reaching new all-time highs on Friday, the IPO of AB InBev’s Asian subsidiary, which would have been the largest flotation of the year, was pulled due to weak demand from institutional investors. 

In the UK, ReAssure, the UK closed book life insurance division of Swiss ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 257,135.72 1154 8.48%
2 Citi 233,987.92 977 7.71%
3 Bank of America Merrill Lynch 200,291.91 822 6.60%
4 Barclays 184,724.40 755 6.09%
5 HSBC 145,122.12 803 4.78%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 BNP Paribas 31,351.09 133 7.80%
2 Credit Agricole CIB 27,347.56 115 6.80%
3 JPMorgan 23,350.32 62 5.81%
4 Bank of America Merrill Lynch 22,838.09 62 5.68%
5 UniCredit 19,966.03 111 4.97%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 8,160.55 49 10.08%
2 Morgan Stanley 7,744.92 38 9.57%
3 Goldman Sachs 6,966.15 37 8.61%
4 Citi 5,856.44 44 7.24%
5 UBS 4,823.67 25 5.96%